Brief: SSY Receives Approval For Drug Production, Registration For Nicardipine Hydrochloride Injection From NMPA China
31/03/2025 10:52
March 31 (Reuters) - SSY Group Ltd 2005.HK: APPROVAL FOR DRUG PRODUCTION AND REGISTRATION FOR NICARDIPINE HYDROCHLORIDE INJECTION (10ML:10MG) IN FORM OF AMPOULE FROM NMPA CHINA Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth